42: Biosimilars; What, How, When?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
42: Biosimilars; What, How, When?
-
Narrated by:
-
By:
Please join your host, Justin Baker, as he learns from industry experts, Connor Nell and Brian Biehn, why biosimilars are becoming such an eye-opening opportunity, and why independents need to take a hard look at them.
In addition to being an alternative to expensive brand name drugs, the breadth of biosimilars is growing exponentially, and gaining acceptance with physicians, pharmacists and patients.
This countertop chat dives deeply into increasing access, understanding their benefits, and gaining confidence in these emerging therapies.
adbl_web_anon_alc_button_suppression_t1
No reviews yet